Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
1.220
-0.080 (-6.15%)
At close: Feb 12, 2026, 4:00 PM EST
1.260
+0.040 (3.28%)
After-hours: Feb 12, 2026, 4:42 PM EST
Bone Biologics Market Cap
Bone Biologics has a market cap or net worth of $2.19 million as of February 12, 2026. Its market cap has decreased by -9.33% in one year.
Market Cap
2.19M
Enterprise Value
-3.79M
1-Year Change
-9.33%
Ranking
Category
Stock Price
$1.22
Market Cap Chart
Since March 31, 2016, Bone Biologics's market cap has decreased from $155.72M to $2.19M, a decrease of -98.59%. That is a compound annual growth rate of -35.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 2.33M | -10.34% |
| Dec 31, 2025 | 2.60M | 12.38% |
| Dec 31, 2024 | 2.32M | -4.06% |
| Dec 29, 2023 | 2.41M | -24.75% |
| Dec 30, 2022 | 3.21M | -91.19% |
| Dec 31, 2021 | 36.43M | -58.55% |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jaguar Health | 2.91M |
| Artelo Biosciences | 2.91M |
| Propanc Biopharma | 2.67M |
| Lyra Therapeutics | 2.61M |
| PMGC Holdings | 2.59M |
| CNS Pharmaceuticals | 2.54M |
| Cardio Diagnostics Holdings | 2.50M |
| CDT Equity | 2.44M |